Skip to main content
Download PDF

Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity

Stem Cell Research & Therapy volume 9, Article number: 269 (2018) Cite this article

The Original Article was published on 23 August 2018

Correction

The original article [1] contains an error regarding the erroneous inclusion of 3 μl as a parameter in the x-axis of Fig. 2c; the correct version of Fig. 2c can instead be seen below.

Fig. 2
figure 1

Effects of H2O2 and PJ34 treatment on EPC protein expression. a, b Expression of sirtuin 1 (SIRT1), poly (ADP-ribose) polymerase 1 (PARP1), and poly ADP-ribose (PAR) as analyzed by Western blot. c, d Expression of PARP1, PAR, and acetylated (ac)-p53 as analyzed by Western blot. *P < 0.05, **P < 0.01, ***P < 0.001, versus the control

Full size image

Reference

  1. Zha S, et al. PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity. Stem Cell Res Ther. 2018;9:224 https://doi.org/10.1186/s13287-018-0961-7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Geriatrics, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Siyuan Zha, Zhen Li, Qing Cao, Fei Wang & Fang Liu

Authors
  1. Siyuan Zha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qing Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fang Liu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zha, S., Li, Z., Cao, Q. et al. Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity. Stem Cell Res Ther 9, 269 (2018). https://doi.org/10.1186/s13287-018-1019-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13287-018-1019-6

Stem Cell Research & Therapy

ISSN: 1757-6512